- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04646278
Coronary Hemodynamics by Coronary Angiography (ESCARGOT)
Estimation of Coronary Artery Hemodynamic Profiles Using Cineangiography Technique
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
* Methods: Compare TIMI frame count, coronary clearance frame count in baseline/hyperemic coronary angiography with FFR, CFR, IMR and derive correlation, receiver-operating characteristic curve to find new tools estimating coronary hemodynamics by conventional angiography only.
A TIMI frame count is measured by counting the angiographic image cine frames during a head of radiocontrast column runs from the entry of left anterior descending artery (LAD) to the distal end.
A coronary clearance frame count is measured by counting the angiographic image cine frames during a tail of radiocontrast column runs from the entry of LAD to the distal end.
Baseline angiography is performed without any stimulation and hyperemic angiography is performed after intracoronary injection of adenosine 300ug or nicorandiol 2mg.
Inclusion criteria
- Patient who underwent physiologic study using a pressure wire for intermediate coronary lesion after coronary angiography
Exclusion criteria
- ST elevation myocardial infarction
- Cardiogenic shock
- Congestive heart failure with pulmonary edema
- LVEF < 30%
- Previous history of coronary revascularization
- Chronic total occlusion
- 3 vessel disease
- Target lesion at distal segments or branches
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gangwon-do
-
Chuncheon, Gangwon-do, Korea, Republic of, 24289
- Kangwon National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- Patient who underwent physiologic study using a pressure wire for intermediate coronary lesion after coronary angiography
Exclusion criteria
- ST elevation myocardial infarction
- Cardiogenic shock
- Congestive heart failure with pulmonary edema
- LVEF < 30%
- Previous history of coronary revascularization
- Chronic total occlusion
- 3 vessel disease
- Target lesion at distal segments or branches
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Hyperemic stimuli
Hyperemic stimuli of coronary flow by adenosine or nicorandil injection
|
Hyperemic simuli of coronary flow by adenosine or nicorandil injection
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
TIMI frame count
Time Frame: Imediately after the procedure
|
frame count between the beginning and end of contrast column head
|
Imediately after the procedure
|
Coronary Clearance Frame Count
Time Frame: Imediately after the procedure
|
frame count between the beginning and end of contrast column tail
|
Imediately after the procedure
|
Index of microcirculatory resistance
Time Frame: During the procedure
|
derived from distal coronary pressure by transit time
|
During the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fractional flow reserve
Time Frame: During the procedure
|
measured by pressure wire
|
During the procedure
|
Coronary flow reserve
Time Frame: During the procedure
|
measured by pressure wire by thermodilution technique
|
During the procedure
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-2017-01-012-015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaRecruitingCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationKorea, Republic of
Clinical Trials on Hyperemic stimuli
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyUnknown
-
Leiden University Medical CenterCenter for Medical Systems Biology; Roba Metals BV, IJsselsteinCompletedAging | Calorie Restriction
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Laval UniversityOpsens, Inc.; International Chair on Interventional Cardiology and Transradial...RecruitingCoronary Artery Disease | Chest Pain | Ischemic Heart Disease | Stable Angina | Unstable AnginaCanada
-
University of BaselHorizon 2020 - European CommissionNot yet recruitingLight FlashingSwitzerland
-
IRCCS Burlo GarofoloRecruitingHearing Impaired ChildrenItaly
-
Harvard Medical School (HMS and HSDM)Not yet recruiting
-
Simon Fraser UniversityNot yet recruitingSyncope, Vasovagal | Blood, Injection, Injury Type PhobiaCanada
-
Université de SherbrookeCentre hospitalier de l'Université de Montréal (CHUM); Réseau de bio-imagerie...CompletedDiffuse and Focal Liver Diseases, Cerebral FunctionCanada